|
MDXG
|
MiMedx Group, Inc
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MOR
|
MorphoSys AG
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
US
|
NASDAQ
|
|
MYMD
|
MyMD Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
|
OABI
|
OmniAb, Inc.
|
US
|
NASDAQ
|
|
OKYO
|
OKYO Pharma Limited
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
PRTG
|
Portage Biotech Inc.
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PTIX
|
Protagenic Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
REVB
|
Revelation Biosciences, Inc.
|
US
|
NASDAQ
|
|
RUBY
|
Rubius Therapeutics, Inc.
|
US
|
NASDAQ
|